(Q36615163)

15 August 2017

Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk (English)

1 reference

15 August 2017

1 reference

13

H Grönberg

1 reference

15 August 2017

11

H-O Adami

1 reference

15 August 2017

F Lindmark

1

1 reference

15 August 2017

S L Zheng

2

1 reference

15 August 2017

F Wiklund

3

1 reference

15 August 2017

K A Bälter

4

1 reference

15 August 2017

J Sun

5

1 reference

15 August 2017

B Chang

6

1 reference

15 August 2017

M Hedelin

7

1 reference

15 August 2017

J Clark

8

1 reference

15 August 2017

J-E Johansson

9

1 reference

15 August 2017

D A Meyers

10

1 reference

15 August 2017

W Isaacs

12

1 reference

15 August 2017

J Xu

14

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

93

1 reference

15 August 2017

4

1 reference

15 August 2017

493-497

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602729

15 August 2017

0 references

cites work

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361575

Epidemiologic association between prostatitis and prostate cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361575

Chronic inflammation and cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361575

Score tests for association between traits and haplotypes when linkage phase is ambiguous

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361575

Influence of interleukin-1 receptor antagonist gene polymorphism on disease

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361575

Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361575

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361575

An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361575

MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361575

Biology of interleukin 1.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361575

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361575

The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361575

H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361575

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361575

Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602729

Influence of cytokine gene polymorphisms on the development of prostate cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361575

Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus

21 October 2018

1 reference

12 December 2020

Sequence Variants in Toll-Like Receptor Gene Cluster (TLR6-TLR1-TLR10) and Prostate Cancer Risk

1 reference

12 December 2020

Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer

1 reference

12 December 2020

Nucleotide variation, haplotype structure, and association with end-stage renal disease of the human interleukin-1 gene cluster

1 reference

12 December 2020

Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6602729

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

16106254

1 reference